Ramona Optics Raises $25 Million Series A to Transform Biomedical Research with Massively Parallel Microscopy

DURHAM, N.C.--(BUSINESS WIRE)--Ramona Optics, Inc. (“Ramona”), a leading biotools company advancing human health with massively parallel computational imaging that delivers unrivaled precision and scale to biopharma and biomedical customers, today announced the closing of an oversubscribed $25 million Series A financing round. The round was led by ARCH Venture Partners, with participation from Stealthpoint Ventures, ND Capital, Fall Line Capital, Hamamatsu Ventures, Murchison Capital Partners,